Clinical outcomes of metastatic urothelial carcinoma pts discontinuing enfortumab vedotin. Correlation between expression of urinary exosomal m6A-RMRP and clinicopathological characteristics in BCa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results